ORDRE DU JOUR
SESSION OBJECTIVES
Friday, November 8
​
RETINA SESSION 1
Objectives:
-
To review the use of state-of-the-science imaging for establishing diagnosis, best treatment, and prognosis of retinal diseases
-
To discuss the important benefits of intraoperative OCT for guiding real-time decisions
-
To provide an update on the contemporary use of injections and lasers
​
GLAUCOMA SESSION 1
Objectives:
-
To review and discuss the current landscape of glaucoma diagnosis and management
-
To challenge participants with real-world case studies as an exercise towards incorporating new perspectives into glaucoma diagnosis and management
-
To examine the clinical rationale and benefits of different uses of OCT in glaucoma
FRIDAY, NOVEMBER 8, 2024
Retina Session I
Glaucoma Session I
SESSION OBJECTIVES
Saturday, November 9 AM
​
RETINA/GLAUCOMA SESSION
Objectives:
-
To review and discuss the current, supportive role of AI in the diagnosis and management of retinal diseases and glaucoma
-
To envision the future versus futuristic role of AI in the diagnosis and management of retinal diseases and glaucoma
-
To address some of today’s greater clinical challenges in the management of glaucoma
-
To review and discuss the strategy of a collaborative, multi-disciplinary approach to the management of retinal disease and glaucoma.
SATURDAY, NOVEMBER 9, 2024
Retina / Glaucoma Session
SESSION OBJECTIVES
Saturday, November 1 PM
​
RETINA SESSION 2
Objectives:
-
To further discuss the sophisticated role of various imaging modalities in the diagnosis, treatment, and monitoring of retinal diseases
-
To shed light on a strategic pathway in the management of Coats Disease
-
To provide insights to the not-always-predictable medical discovery journey
​
GLAUCOMA SESSION 2
Objectives:
-
To further discuss the sophisticated role of various imaging modalities in the diagnosis, treatment, and monitoring of glaucoma
-
To challenge participants with real-world case studies as an exercise towards incorporating new perspectives into glaucoma diagnosis and management
-
To provide insights to the not-always-predictable medical discovery journey